A variant Burkitt-type translocation (8;22)(q24;q11) in multiple myeloma: Report of a new case and review of the literature

Cancer Genetics and Cytogenetics

Volumn 104, Issue 2, 1998, Pages 98-103

  Yamamoto, Katsuya ^a   Hamaguchi, Hiroyuki ^a   Nagata, Kaoru ^a   Taniwaki, Masafumi ^b  

^a Department of Hematology Musashino Red Cross H ^*  (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; MELPHALAN; METHYLPREDNISOLONE; MYC PROTEIN; NIMUSTINE; VINCRISTINE; VINDESINE;

AGED; ARTICLE; BURKITT LYMPHOMA; CANCER STAGING; CASE REPORT; CHROMOSOME 22; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 8; FEMALE; HUMAN; MULTIPLE MYELOMA; ONCOGENE; ONCOGENE C MYC; PLASMA CELL; PRIORITY JOURNAL; YEAST ARTIFICIAL CHROMOSOME;

EID: 0032527579     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00458-5     Document Type: Article

References (18)

1. Mitelman F (1994): Catalog of Chromosome Aberrations in Cancer. ed 5, Wiley-Liss, New York.
2. Gould J., Alexanian R., Goodacre A., Pathak S., Hecht B., Barlogie B. Plasma cell karyotype in multiple myeloma. Blood. 71:1988;453-456.
3. Weh H.J., Gutensohn K., Selbach J., Kruse R., Wacker-Backhaus G., Seeger D., Fiedler W., Fett W., Hossfeld D.K. Karyotype in multiple myeloma and plasma cell leukaemia. Eur J Cancer. 29A:1993;1269-1273.
4. Taniwaki M., Nishida K., Takashima T., Nakagawa H., Fujii H., Tamaki T., Shimazaki C., Horiike S., Misawa S., Abe T., Kashima K. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood. 84:1994;2283-2290.
5. Lai J.L., Zandecki M., Mary J.Y., Bernardi F., Izydorczyk V., Flactif M., Morel P., Jouet J.P., Bauters F., Facon T. Improved cytogenetics in multiple myeloma. a study of 151 patients including 117 patients at diagnosis Blood. 85:1995;2490-2497.
6. Sawyer J.R., Waldron J.A., Jagannath S., Barlogie B. Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet. 82:1995;41-49.
7. Calasanz M.J., Cigudosa J.C., Odero M.D., Ferreira C., Ardanaz M.T., Fraile A., Carrasco J.L., Sole F., Cuesta B., Gullon A. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders. primary breakpoints and clinical correlations Genes Chromosom Cancer. 18:1997;84-93.
8. Sole F., Woessner S., Acin P., Perez-Losada A., Florensa L., Besses C., Sans-Sabrafen J. Burkitt's type translocation in multiple myeloma. Leukemia Res. 18:1994;671-673.
9. Look R.M., Lim S.W., Schreck R.R., Lee S., Fuerst M.P., Lawrence G.N., Kusuanco D.A., Kessler C.E., Giles F.J. Burkitt translocation (8;22)(q24;q11) in a patient with multiple myeloma. Cancer Genet Cytogenet. 82:1995;100-102.
10. Mugneret F., Sidaner I., Favre B., Manone L., Maynadie M., Caillot D., Solary E. Der(16)t(1;16)(q10;p10) in multiple myeloma. a new non-random abnormality that is frequently associated with Burkitt's-type translocations Leukemia. 9:1995;277-281.
11. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
12. Veronese M.L., Ohta M., Finan J., Nowell P.C., Croce C.M. Detection of myc translocations in lymphoma cells by fluorescence in situ hybridization with yeast artificial chromosomes. Blood. 85:1995;2132-2138.
13. Lengauer C., Riethman H.C., Speicher M.R., Taniwaki M., Konecki D., Green E.D., Becher R., Olson M.V., Cremer T. Metaphase and interphase cytogenetics with Alu-PCR-amplified yeast artificial chromosome clones containing the BCR gene and the protooncogenes c-raf-1, c-fms, and c-erbB-2. Cancer Res. 52:1992;2590-2596.
14. Taniwaki M., Nishida K., Ueda Y., Misawa S., Nagai M., Tagawa S., Yamagami T., Sugiyama H., Abe M., Fukuhara S., Kashima K. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization. Blood. 85:1995;3223-3228.
15. Yamamoto K., Hamaguchi H., Nagata K., Kobayashi M., Tanimoto F., Taniwaki M. Establishment of a novel human acute myeloblastic leukemia cell line (YNH-1) with t(16;21), t(1;16) and 12q13 translocations. Leukemia. 11:1997;599-608.
16. Zeidler R., Joos S., Delecluse H.J., Klobeck G., Vuillaume M., Lenoir G.M., Bornkamm G.W., Lipp M. Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC. Genes Chromosom Cancer. 9:1994;282-287.
17. Selvanayagam P., Blick M., Narni F., van Tuinen P., Ledbetter D.H., Alexanian R., Saunders G.F., Barlogie B. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood. 71:1988;30-35.
18. Nobuyoshi M., Kawano M., Tanaka H., Ishikawa H., Tanabe O., Iwato K., Asaoku H., Sakai A., Kuramoto A. Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells. Br J Haematol. 77:1991;523-528.